Literature DB >> 12457713

Plasmalogen content and beta-adrenoceptor signalling in fibroblasts from patients with Zellweger syndrome. Effects of hexadecylglycerol.

Regula Styger1, Ulrich N Wiesmann, Ulrich E Honegger.   

Abstract

In Zellweger or cerebro-hepato-renal syndrome (CHRS), the assembly of peroxisomes is defective, resulting in deficient plasmalogen formation. Plasmalogens are part of the membrane lipid composition. In fibroblasts of CHRS patients, the plasmalogen fraction of phosphatidylethanolamine (PPE) was about half of that in control cells while total phospholipid (PL) content, individual PL and plasma membrane fluidity were normal. CHRS cell strains had higher beta-adrenoceptor numbers and isoproterenol-stimulated cAMP responses. Receptors were more efficiently coupled to adenylate cyclase than in control cells. Stimulations of cAMP with NaF or forskolin were the same as in control cells. Restoring synthesis of plasmalogens with hexadecylglycerol (HDG), a plasmalogen precursor, resulted in a proportionate increase in PPE of about 40% in both control and CHRS fibroblasts. Exposure to HDG reduced surface beta-adrenoceptor sites and cAMP-responses to isoproterenol in CHRS cells only, while post-receptor stimulations of cAMP were reduced in both cell types. Plasmalogen contents inversely correlated with isoproterenol-stimulated cAMP levels. The increased numbers of functional beta-adrenoceptors in CHRS fibroblasts may be the result of a higher expression and/or of a prolonged functional half-life of the receptor protein. In vivo, this may contribute to the clinical manifestations of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457713     DOI: 10.1016/s1388-1981(02)00320-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  The ether lipid precursor hexadecylglycerol protects against Shiga toxins.

Authors:  Jonas Bergan; Tore Skotland; Anne Berit Dyve Lingelem; Roger Simm; Bjørn Spilsberg; Toril Lindbäck; Tuulia Sylvänne; Helena Simolin; Kim Ekroos; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2014-04-18       Impact factor: 9.261

2.  A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton.

Authors:  Nancy Braverman; Rui Zhang; Li Chen; Graeme Nimmo; Sarah Scheper; Tammy Tran; Rupsa Chaudhury; Ann Moser; Steven Steinberg
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

3.  Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice.

Authors:  Pedro Brites; Ana Sofia Ferreira; Tiago Ferreira da Silva; Vera F Sousa; Ana R Malheiro; Marinus Duran; Hans R Waterham; Myriam Baes; Ronald J A Wanders
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

4.  Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens.

Authors:  Paul L Wood; M Amin Khan; Tara Smith; Dayan B Goodenowe
Journal:  Lipids Health Dis       Date:  2011-11-16       Impact factor: 3.876

5.  Homeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.

Authors:  Fabian Dorninger; Alexander Brodde; Nancy E Braverman; Ann B Moser; Wilhelm W Just; Sonja Forss-Petter; Britta Brügger; Johannes Berger
Journal:  Biochim Biophys Acta       Date:  2014-11-15

Review 6.  APP Function and Lipids: A Bidirectional Link.

Authors:  Marcus O W Grimm; Janine Mett; Heike S Grimm; Tobias Hartmann
Journal:  Front Mol Neurosci       Date:  2017-03-10       Impact factor: 5.639

7.  The ether lipid precursor hexadecylglycerol causes major changes in the lipidome of HEp-2 cells.

Authors:  Jonas Bergan; Tore Skotland; Tuulia Sylvänne; Helena Simolin; Kim Ekroos; Kirsten Sandvig
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

8.  Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice.

Authors:  Edith Miville-Godbout; Mélanie Bourque; Marc Morissette; Sara Al-Sweidi; Tara Smith; Asuka Mochizuki; Vijitha Senanayake; Dushmanthi Jayasinghe; Li Wang; Dayan Goodenowe; Thérèse Di Paolo
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

Review 9.  Peroxisome Metabolism in Cancer.

Authors:  Jung-Ae Kim
Journal:  Cells       Date:  2020-07-14       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.